Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes

British Journal of Haematology

Volumn 148, Issue 1, 2010, Pages 90-98

  Alfinito, Fiorella ^a   Sica, Michela ^b,d   Luciano, Luigiana ^a   Pepa, Roberta Della ^a   Palladino, Carmela ^a   Ferrara, Idalucia ^a   Giani, Umberto ^b   Ruggiero, Giuseppina ^b   Terrazzano, Giuseppe ^b,c  

^a Dipartimento di Biochimica e Biotecnologie Mediche   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF BASILICATA   (Italy)

^d ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

Bone marrow; Immune mediated pathogenesis; Lymphocytes; Myelodysplastic syndromes; Treg

Indexed keywords

ERYTHROPOIETIN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSERYTHROPOIESIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNE DYSREGULATION; LYMPHOCYTE SUBPOPULATION; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RISK ASSESSMENT; TRANSFUSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ERYTHROPOIESIS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 72249104044     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07921.x     Document Type: Article

References (45)

1. + regulatory T cells in cancer patients. Blood, 107, 2409 2414.
2. Amin, H.M., Jilani, I., Estey, E.H., Keating, M.J., Dey, A.L., Manshouri, T., Kantarjian, H.M., Estrov, Z., Cortes, J.E., Thomas, D.A., Giles, F.J. Albitar, M. (2003) Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome. Blood, 102, 1866 1868.
3. high regulatory cells in human peripheral blood. Journal of Immunology, 167, 1245 1253.
4. Barrett, A.J. (2004) Myelodysplastic syndrome: an example of misguided immune surveillance? Leukemia Research, 28, 1123 1124.
5. Barrett, J., Saunthararajah, Y. Molldrem, J. (2000) Myelodysplastic syndrome and aplastic anaemia: distinct entities or diseases linked by a common pathophysiology? Seminars in Hematology, 37, 15 29.
6. Baumann, I., Scheid, C., Koref, M.S., Swindell, R., Stern, P. Testa, N.G. (2002) Autologous lymphocytes inhibit haemopoiesis in long-term culture in patients with myelodysplastic syndrome. Experimental Hematology, 30, 1405 1411.
7. + regulatory T cells in patients with multiple myeloma. Blood, 107, 3940 3949.
8. Chen, G., Zeng, W., Miyazato, A., Billings, E., Maciejewski, J.P., Kajigaya, S., Sloand, E.M. Young, N.S. (2004) Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood, 104, 4210 4218.
9. Claessens, Y.E., Bouscary, D., Dupont, J.M., Picard, F., Melle, J., Gisselbrecht, S., Lacombe, C., Dreyfus, F., Mayeux, P. Fontenay-Roupie, M. (2002) In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for fas-dependent apoptosis. Blood, 99, 1594 81601.
10. Deeg, H.J., Beckham, C., Loken, M.R., Bryant, E., Lesnikova, M., Shulman, H.M. Gooley, T. (2000) Negative regulators of haemopoiesis and stroma function in patients with myelodysplastic syndrome. Leukemia and Lymphoma, 37, 405 414.
11. Epperson, D.E., Nakamura, R., Saunthararaja, Y., Melenhorst, J. Barrett, A.J. (2001) Oligoclonal T cell expansion in Myelodysplastic syndrome: evidence for an autoimmune process. Leukemia Research, 25, 1075 1083.
12. Feuerer, M., Beckhove, P., Garbi, N., Mahnke, Y., Limmer, A., Hommel, M., Hämmerling, G.J., Kyewski, B., Hamann, A., Umansky, V. Schirrmacher, V. (2003) Bone marrow as a priming site for T-cell responses to blood borne antigen. Nature Medicine, 9, 1151 1157.
13. Greenberg, F., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079 2088.
14. Heaney, M.L Golde, D.W. (1999) Myelodysplasia. New England Journal of Medicine, 340, 1649 1660.
15. Hodge, J.W., Chakraborty, M., Kudo-Saito, C., Garnett, C.T. Schlom, J. (2005) Multiple costimulatory modalities enhance CTL avidity. Journal of Immunology, 174, 5994 6004.
16. Huehn, J. Hamann, A. (2005) Homing to suppress: address codes for Treg migration. Trends in Immunology, 26, 632 636.
17. Jahnke, A. Johnson, J.P. (1995) Intercellular adhesion molecule-1 (ICAM-1) is synergistically activated by TNF-alpha and IFN-gamma responsive sites. Immunobiology, 193, 305 314.
18. Jonásova, A., Neuwirtová, R., Cermák, J., Vozobulová, V., Mociková, K., Sisková, M. Hochová, I. (1998) Cyclosporin: a therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. British Journal of Haematology, 100, 304 309.
19. Killick, S.B., Mufti, G., Cavenagh, J.D., Mijovic, A., Peacock, J.L., Gordon-Smith, E.C., Bowen, D.T. Marsh, J.C. (2003) A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia. British Journal of Haematology, 120, 679 684.
20. Kordasti, S.Y., Ingram, W., Hayden, J., Darling, D., Barber, L., Afzali, B., Lombardi, G., Wlodarski, M.W., Maciejewski, J.P., Farzaneh, F. Mufti, G.J. (2007) CD4+CD25+high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood, 110, 847 850.
21. + regulatory T cells in myelodysplastic syndromes (MDS). Leukemia, 23, 510 518.
22. Li, R., Perez, N., Karumuthil-Melethil, S. Vasu, C. (2007) Bone marrow is a preferential home site for autoreactive T-cells in Type-1 diabetes. Diabetes, 56, 2251 2259.
23. Loken, M.R., Chu, S., Fritschle, W., Kalnoski, M., Denise, A. Wells, D.A. (2009) Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses. Cytometry, 76B, 27 36.
24. Luzzatto, L., Bessler, M. Rotoli, B. (1997) Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell, 88, 1 4.
25. Maciejewski, J.P. (2007) Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones. Folia Histochemica et Cytochemica, 45, 5 14.
26. Malcovati, L., Porta, M.G., Pascutto, C., Invernizzi, R., Boni, M., Travaglino, E., Passamonti, F., Arcaini, L., Maffioli, M., Bernasconi, P., Lazzarino, M. Cazzola, M. (2005) Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. Journal of Clinical Oncology, 23, 7594 7603.
27. Malcovati, L., Germing, U. Kuendgen, A. (2007) Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. Journal Clinical Oncology, 25, 3503 3510.
28. Matloubian, M., Concepcion, R.J. Ahmed, R. (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T cell responses during chronic viral infection. Journal of Virology, 68, 8056 8063.
29. Melenhorst, J.J., Scheinberg, P., Chattopadhyay, P.K., Gostick, E., Ladell, K., Roederer, M., Hensel, N.F., Douek, D.C., Barrett, A.J. Price, D.A. (2009) High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow. Blood, 113, 2238 2244.
30. Miller, M.J., Safrina, O., Parker, I. Cahalan, M.D. (2004) Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. Journal of Experimental Medicine, 200, 847 856.
31. Molldrem, J.J., Leifer, E., Bahceci, E., Saunthararajah, Y., Rivera, M., Dunbar, C., Liu, J., Nakamura, R., Young, N.S. Barrett, A.J. (2002) Antithymocyte globulin for treatment of the bone marrow failure associated with Myelodysplastic Syndromes. Annals of Internal Medicine, 137, 156 163.
32. Palendira, U., Chinn, R., Raza, W., Piper, K., Pratt, G., Machado, L., Bell, A., Khan, N., Hislop, A.D., Steyn, R., Rickinson, A.B., Buckley, C.D. Moss, P. (2008) Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within bone marrow. Blood, 112, 3293 3302.
33. Parker, J.E. Mufti, G.J. (2000) Excessive apoptosis in Low risk myelodysplastic syndromes (MDS). Leukemia and Lymphoma, 40, 1 24.
34. Pellagatti, A., Cazzola, M., Giagounidis, A.A., Malcovati, L., Porta, M.G., Killick, S., Campbell, L.J., Wang, L., Langford, C.F., Fidler, C., Oscier, D., Aul, C., Wainscoat, J.S. Boultwood, J. (2006) Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood, 108, 337 345.
35. Ribeiro, E., Matarraz Sudón, S., de Santiago, M., Lima, C.S., Metze, K., Giralt, M., Saad, S.T., de Matos, A.O. Lorand-Metze, I. (2006) Maturation-associated immunophenotypic abnormalities in bone marrow B lymphocytes in myelodysplastic syndromes. Leukemia Research, 30, 9 16.
36. Ruggiero, G., Sica, M., Luciano, L., Savoia, F., Cosentini, E., Alfinito, F. Terrazzano, G. (2009) A case of myelodysplastic syndrome associated with CD14(+)CD56(+) monocytosis, expansion of NK lymphocytes and defect of HLA-E expression. Leukemia Research, 33, 181 185.
37. + regulatory T cells in immunological tolerance to self and nonself. Nature Immunology, 6, 345 352.
38. Sloand, E.M. Rezvani, K. (2008) The role of the immune system in myelodysplasia: implications for therapy. Seminars in Hematology, 45, 39 48.
39. Sloand, E.M., Mainwaring, L., Fuhrer, M., Ramkissoon, S., Risitano, A.M., Keyvanafar, K., Lu, J., Basu, A., Barrett, A.J. Young, N.S. (2005) Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood, 106, 841 851.
40. Sloand, E.M., Wu, C.O., Greenberg, P., Young, N.S. Barrett, J. (2008) Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. Journal of Clinical Oncology, 26, 2505 2511.
41. Steensma, D.P., Dispenzieri, A., Moore, S.B., Schroeder, G. Tefferi, A. (2003) Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome. Blood, 101, 2156 2158.
42. Sternberg, A., Killick, S., Littlewood, T., Hatton, C., Peniket, A., Seidl, T., Soneji, S., Leach, J., Bowen, D., Chapman, C., Standen, G., Massey, E., Robinson, L., Vadher, B., Kaczmarski, R., Janmohammed, R., Clipsham, K., Carr, A. Vyas, P. (2005) Evidence for reduced B cell progenitors in early (low risk) myelodysplastic syndrome. Blood, 106, 2982 2991.
43. Wei, S., Kryczek, I. Zou, W. (2006) Regulatory T-cell compartimentalization and trafficking. Blood, 108, 426 431.
44. Zeng, W., Miyazato, A., Chen, G., Kajigaya, S., Young, N.S. Maciejewski, J.P. (2006) Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood, 107, 167 175.
45. Zuckerman, I.A., Pullen, I. Miller, J. (1998) Functional consequences of costimulation by ICAM-1 on T cell activation. Journal of Immunology, 160, 3259 3268.